Smith & Nephew slashes guidance as China slowdown continues Retail Hip and knee implant maker Smith & Nephew has cut its full-year guidance as it continues to grapple with a slowdown in China. It booked third quarter revenue of $1.4bn (£1.08bn), up four per cent year on year, but Chinese sales dragged as the region experienced “worse than expected headwinds” across the surgical businesses. The [...]
This may hurt: English High Court set for Moderna and Pfizer/BioNTech Covid battle starting today LEGAL The English part of a global dispute billion dollar legal case involving big pharma giants Modern, Pfizer and BioNTech over Covid patents, kicks off today.
Smith and Nephew lifts outlook as medical device revenue growth offsets China slowdown industrials It wasn't all plain sailing for the medical tech giant however, with its operating profit for the year down to £335m, from £356m.